Basis (4068) · InitiativeRestated
Stock Acquisition Rights Incentive Linked to Medium-Term Performance Targets
First written in FY2025. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Stock acquisition rights with combined EBITDA and revenue conditionsA theme 3 companies write about · 0 as a headwind · 3 as a tailwind
0 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「(a) If EBITDA exceeds ¥1 billion in any fiscal year from the fiscal year ending June 2027 through the fiscal year ending June 2030: exercisable proportion 70%」
The Series 4 and Series 5 medium-term performance-linked Stock Acquisition Rights introduced in FY2025 remained outstanding in FY2026, with conditions including EBITDA exceeding ¥1 billion and consolidated revenue exceeding ¥10 billion continuing to apply. - FY2025First statedAnnual report
「(a) If EBITDA exceeds ¥1 billion in any fiscal year from the fiscal year ending June 2027 through the fiscal year ending June 2030: 70% exercisable (b) If consolidated revenue exceeds ¥10 billion in any fiscal year from the fiscal year ending June 2026 through the fiscal year ending June 2028: 30% exercisable」
In August 2025, the company issued its fourth series of stock acquisition rights for employees, linking the exercisable percentages to the mid-term performance conditions of EBITDA exceeding ¥1 billion and consolidated revenue exceeding ¥10 billion. The fifth series of stock acquisition rights also provides for a 30% exercisable tranche after the start of the exercise period.